COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,591 Articles (22,905 medRxiv, 8,686 bioRxiv)

Most recent first Previous |  Page 281: Articles 2801-2810  | Next

Resolution of SARS-CoV-2 infection in human lung tissues is driven by extravascular CD163+ monocytes
Kenney, D. J., O'Connell, A. K., Tseng, A. E., Turcinovic, J., Sheahan, M. L., Nitido, A. D., Montanaro, P., Gertje, H. P., Ericsson, M., Connor, J. H., Vrbanac, V., Crossland, N. A., Harly, C., Balazs, A. B., Douam, F.
10.1101/2024.03.08.583965 — Posted: 2024-03-08
COVID-19 Vaccination Booster Uptake Is Related to End of Pandemic Perception: Population-Based Survey in Four Provinces in Indonesia
Maula, A. W., indriani, c., Arisanti, R. R., Testamenti, V. A., Praptiningsih, C. Y., Merril, R., Ansariadi, A., Wahyono, T. Y. M., Hidajah, A. C., AHMAD, R. A.
10.1101/2024.03.05.24303828 — Posted: 2024-03-07
Accelerated brain age in young to early middle-aged adults after mild to moderate COVID-19 infection
Kesler, S. R., Franco-Rocha, O. Y., De La Torre Schutz, A., Lewis, K. A., Aziz, R., Brode, M., Melamed, E.
10.1101/2024.03.05.24303816 — Posted: 2024-03-07
The importance of mothers: The social transmission of COVID-19 vaccination attitudes and uptake
Thompson, O., Cristea, M., Tamariz, M.
10.1101/2024.03.06.24303875 — Posted: 2024-03-07
Predictors of mortality among COVID-19 patients at Kilimanjaro Christian Medical Centre in Northern Tanzania: A hospital-based retrospective cohort study
Waria, G. G., Muro, F. J., Jonas, N., Sakita, F., Shirima, L., Mlay, H. L., Ngowi, M., Meela, E. B., Mboya, I. B., Kilonzo, K. G.
10.1101/2024.03.05.24303842 — Posted: 2024-03-07
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Roederer, A. L., Cao, Y., St. Denis, K., Sheehan, M. L., Li, C. J., Lam, E. C., Gregory, D. J., Poznansky, M. C., Iafrate, A. J., Canaday, D. H., Gravenstein, S., Garcia-Beltran, W. F., Balazs, A. B.
10.1101/2024.03.05.24303815 — Posted: 2024-03-07
Contact behaviour before, during and after the COVID-19 pandemic in the Netherlands: evidence from contact surveys in 2016-2017 and 2020-2023
Backer, J. A., Vos, E. R. A., den Hartog, G., van Hagen, C. C. E., de Melker, H. E., van der Klis, F. R. M., Wallinga, J.
10.1101/2024.03.06.24303851 — Posted: 2024-03-07
Community level variability in Bronx COVID-19 hospitalizations associated with differing viral variant adaptive strategies during the second year of the pandemic.
Forster, R. M., Griffen, A., Daily, J., Kelly, L.
10.1101/2024.03.05.24303791 — Posted: 2024-03-07
Estimating the impact of public health interventions on COVID mortality in the United States using reductions in influenza mortality as an indicator of non-pharmaceutical infection control
Morris, R. D.
10.1101/2024.03.06.24303834 — Posted: 2024-03-07
Coronavirus Nucleocapsid Protein Enhances the binding of p-PKCα to RACK1: Implications for Inhibition of Nucleocytoplasmic Trafficking and Suppression of the Innate Immune Response
Liao, Y., Xue, W., Chu, H., Wang, J., Sun, Y., Qiu, X., Song, C., Tan, L., Ding, C.
10.1101/2024.03.06.583677 — Posted: 2024-03-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).